ATEC241220P12500
- 3.00
- 0.000.00%
Alphatec Newsroom
ATEC to Present at the 2025 J.P. Morgan Healthcare Conference
Alphatec Management to Meet Virtually With Jefferies
Alphatec Holdings (ATEC) Slid on Higher Than Expected Cash Burn Guidance
Alphatec Assumed With an Equal Weight at Morgan Stanley
Alphatec Is Maintained at Overweight by Barclays
Alphatec Holdings Analyst Ratings
Institutional Owners May Take Dramatic Actions as Alphatec Holdings, Inc.'s (NASDAQ:ATEC) Recent 12% Drop Adds to One-year Losses
Barclays Maintains Alphatec(ATEC.US) With Buy Rating, Raises Target Price to $20
Alphatec Files Secondary Stock Shelf to Cover Exercise of Warrants
Alphatec Files to Sell 1.13M Shares of Common Stock for Holders
Stifel Maintains Alphatec(ATEC.US) With Buy Rating, Maintains Target Price $15
Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Avanos Medical (AVNS) and Alphatec Holdings (ATEC)
ATEC to Participate in Upcoming Conferences
Morgan Stanley Maintains Alphatec(ATEC.US) With Hold Rating, Raises Target Price to $9.5
Earnings Update: Alphatec Holdings, Inc. (NASDAQ:ATEC) Just Reported Its Third-Quarter Results And Analysts Are Updating Their Forecasts
Barclays Maintains Alphatec(ATEC.US) With Buy Rating, Maintains Target Price $19
A Quick Look at Today's Ratings for Alphatec(ATEC.US), With a Forecast Between $12 to $22.5
The Market Lifts Alphatec Holdings, Inc. (NASDAQ:ATEC) Shares 50% But It Can Do More
Alphatec Holdings Shares Rise 37% on Narrower 3Q Loss, Higher FY24 Revenue Guidance
Top Midday Gainers